- Home
- CPBI vs ITRM Comparison
CPBI vs ITRM Comparison
Compare CPBI & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- ITRM
- Stock Information
- Founded
- CPBI 2023
- ITRM 2015
- Country
- CPBI United States
- ITRM Ireland
- Employees
- CPBI N/A
- ITRM N/A
- Industry
- CPBI
- ITRM Biotechnology: Pharmaceutical Preparations
- Sector
- CPBI
- ITRM Health Care
- Exchange
- CPBI Nasdaq
- ITRM Nasdaq
- Market Cap
- CPBI 56.2M
- ITRM 49.5M
- IPO Year
- CPBI N/A
- ITRM 2018
- Fundamental
- Price
- CPBI $14.50
- ITRM $1.54
- Analyst Decision
- CPBI
- ITRM Strong Buy
- Analyst Count
- CPBI 0
- ITRM 1
- Target Price
- CPBI N/A
- ITRM $5.00
- AVG Volume (30 Days)
- CPBI 6.3K
- ITRM 671.4K
- Earning Date
- CPBI 01-01-0001
- ITRM 11-14-2024
- Dividend Yield
- CPBI N/A
- ITRM N/A
- EPS Growth
- CPBI N/A
- ITRM N/A
- EPS
- CPBI 0.89
- ITRM N/A
- Revenue
- CPBI $18,262,000.00
- ITRM N/A
- Revenue This Year
- CPBI N/A
- ITRM N/A
- Revenue Next Year
- CPBI N/A
- ITRM N/A
- P/E Ratio
- CPBI $16.21
- ITRM N/A
- Revenue Growth
- CPBI 37.54
- ITRM N/A
- 52 Week Low
- CPBI $9.91
- ITRM $0.81
- 52 Week High
- CPBI $15.50
- ITRM $3.02
- Technical
- Relative Strength Index (RSI)
- CPBI 47.28
- ITRM 39.39
- Support Level
- CPBI $14.50
- ITRM $1.58
- Resistance Level
- CPBI $14.80
- ITRM $2.10
- Average True Range (ATR)
- CPBI 0.37
- ITRM 0.14
- MACD
- CPBI -0.05
- ITRM -0.04
- Stochastic Oscillator
- CPBI 28.09
- ITRM 11.11
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.